About this trial
This study aims to explore the mechanisms of how transcranial magnetic stimulation (TMS) impacts fear circuits. The overarching objectives are to understand how varying TMS parameters affect targeted brain regions in order to optimize its impact on enhancing fear extinction memory consolidation in a population with known fear extinction deficiencies: post-traumatic stress disorder (PTSD). 250 subjects will take part in this research study across UTHealth Houston. The study will include preliminary screenings, baseline visits, and experimental visits across four days
Eligibility criteria
Qualifiers
Willing and able to provide informed consent.
Inclusion Criteria for PTSD Subjects - Diagnosis of current PTSD
Inclusion Criteria: Healthy Controls (HC) - no current psychiatric disorders ("Axis I" disorders)
Disqualifiers
Lifetime history of seizure or significant head trauma or other significant neurologic disease (e.g., tic disorder)
History of serious/significant psychiatric diagnoses ("Axis I" diagnoses)
Current significant suicidal ideation, plan or intent or suicidal behavior in past 6 months based on CSSRS and clinical judgment or Self-injurious behavior that involves suicidal intent, requires medical attention, or occurs daily
Use of neuroleptics within one year prior to study
Trial design
Treatments tested in this trial
- Transcranial magnetic stimulation (TMS)
- Fear Conditioning and Extinction Paradigm
Treatment groups
Locations
1Sponsors and collaborators
The University of Texas Health Science Center, Houston
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator